07.22.21
Rank: #24 (Last year: #25)
$4.22 Billion ($30.6 Billion)
Prior Fiscal: $4.02 Billion
Percentage Change: -4.9%
No. of Employees: 181,897 (total)
Global Headquarters: Tustin, Calif.
KEY EXECUTIVES:
Fujio Mitarai, Chairman and CEO, Canon Global
Toshizo Tanaka, Exec. VP and CFO, Canon Global
Toshio Homma, Exec. VP and Chief Technology Officer, Canon Global
Yuji Hamada, President and CEO, Canon Medical Systems USA Inc.
John Patterson, Sr. VP, CFO and Treasurer, Canon Medical Systems USA Inc.
Satrajit Misra, Chief Sales and Marketing Officer, Canon Medical Systems USA Inc.
Canon Group’s medical division developed and offered a suite of total solutions for diagnosing COVID-19 infections last year, including CT equipment, diagnostic X-ray and ultrasound systems, rapid genetic testing, and rapid antigen testing.
The firm also partnered with Japan’s Nagasaki University to develop and launch reagents for clinical COVID-19 RNA testing for novel coronavirus genes, used to test crew members and passengers of a cruise ship stuck in Nagasaki. Developed through joint research with Yokohama City University, Canon Medical launched sales of a COVID-19 antigen test kit as well. In the U.K., the Bradford Royal Infirmary took delivery of a Relocatable CT scanner equipped with a complete X-ray diagnostic system, making diagnostic imaging possible wherever needed and reducing infection risk among healthcare professionals.
Canon’s Medical Systems business comprised 13.8 percent of the company’s sales last year. The franchise offers digital radiography systems, diagnostic X-ray and ultrasound systems, CT and MRI scanners, clinical chemistry analyzers, and ophthalmic equipment.
The business segment accrued $4.22 billion of revenue last year, almost a 5 percent drop from the year prior. COVID-19 caused the delay of large equipment installations and business negotiations, but CT system demand for pneumonia diagnosis helped prevent further revenue losses. Diagnostic X-ray demand was also strong due to support to emergency medical system maintenance.
Last February the firm achieved FDA clearance for its Aquilion ONE/PRISM Edition CT scanner that enabled deep learning spectral capabilities for more routine spectral imaging. The clearance helps make more confident diagnoses thanks to rapid kV switching with patient-specific mA modulation, full field of view acquisition, and 16 cm of coverage.
A month later, the company won 510(k) clearance for Advanced intelligent Clear-IQ Engine (AiCE) on its Vantage Galan 3T MR system. Trained using enormous amounts of high-quality image data, AiCE’s deep learning neural network reduces noise and boosts signal to acquire sharp, clear, and distinct images. Vantage Galan 3T was also FDA cleared for Compressed SPEEDER technology in March, which speeds MRI scan times by reconstructing full-resolution images from under-sampled data via iterative reconstruction. In June, the technology was cleared for the Vantage Orian 1.5T MR system. Vantage Orian 1.5T MR was FDA cleared for AiCE technology in July as well.
Last April saw the release of the Aquilion Prime SP CT system, a deployable CT with a rapid decontamination solution. It’s deployable in a modular or mobile configuration, and its automated UV-C technology significantly reduces bacteria, spores, and viruses. Multiple UV-C emitters collaborate to decontaminate the room in minutes.
Designed for structural and coronary imaging’s evolving needs, the Aquilion ONE/GENESIS SP cardiovascular CT was introduced last July. It touts one-beat, whole heart acquisition and AiCE Deep Learning Reconstruction (DLR), automated tools from acquisition through analysis, a lower total cost of ownership, a 78 cm bore, and a wide and low couch.
Canon Medical launched the SOLTUS 500 mobile digital X-ray in August. It has a compact design with features to promote efficiency and safety, including tubehead controls and touchscreen display, increased detector wireless range and productivity, anti-collision technologies, pressure-sensitive steering, and simplified detector charging and storage capacity.
Aquilion Exceed LB CT was introduced during last October’s American Society for Radiation Oncology (ASTRO) annual meeting. It features AiCE DLR technology, a 90 cm bore opening, edge-to-edge extended field-of-view reconstruction, and 4 cm of detector coverage. The system is still pending FDA 510(k) clearance.
In November, the firm expanded AiCE DLR to additional modalities, clinical indications, and systems. It showcased AiCE DLR for the Cartesion Prime Digital PET/CT system at last year’s Radiological Society of North America (RSNA) meeting. The indication is pending FDA clearance.
The OMNERA 500A digital radiography system rolled out in November. The system enhances productivity via quiet, smooth auto-positioning, tube and detector auto-tracking, titling wall stand synchronization, and table/wall stand detector charging. System controls are strategically placed on the overhead tube crane (OTC). A specifically designed glass overlay OTC display facilitates cleaning and disinfection.
Also in November, Canon introduced Deep Learning Spectral CT for cardiovascular imaging, which enabled one-beat spectral cardiac CT imaging on the Aquilion ONE/PRISM edition CT. Thanks to a 16 cm wide area detector, the whole heart can be imaged in as little as 0.275 seconds, according to the company.
November was a very busy month for Canon Medical: it also saw the release of Automation Platform AUTOStroke software for CT scanners. The clinical workflow automation solution for CT uses deep learning AI algorithms to automatically complete stroke triage and identify large vessel occlusions or intracranial hemorrhages. When it spots a critical case needing immediate attention, it sends an alert so clinicians can mobilize and respond as quickly as possible.
The Aplio i-series ultrasound platform was endowed with a new liver reporting tool in December. The program uses measurements gathered via Shear Wave Elastography, which provides quantitative measure and dynamic visual display of liver tissue stiffness. The system also provides standard deviation and interquartile range data, as well as a simple visual propagation map, to ensure an accurate and confident “Rule of Four” application to determine cACLD and for assessment of other liver pathologies.
The company unveiled three expanded digital service solutions in December:
A new size for the Hi-Def flat panel detector was introduced in December as well. According to Canon, the 12×16 Hi-Def detector provides over twice the spatial resolution of conventional flat panel detectors, helping see fine details in complex abdominal and peripheral procedures, including peripheral vessel stent placements, GI bleeding embolization, and endovascular leak repairs. The new size was made available for the Alphenix Sky + and Alphenix 4D CT with Sky + systems.
Compressed SPEEDER technology was FDA-cleared for 3D sequences on the Vantage Orian 1.5T in December. Compressed SPEEDER 3D boosts MRI scan times during 3D sequences for surgical planning and orthopedic applications by reconstructing full resolution images from under-sampled data through iterative reconstruction.
$4.22 Billion ($30.6 Billion)
Prior Fiscal: $4.02 Billion
Percentage Change: -4.9%
No. of Employees: 181,897 (total)
Global Headquarters: Tustin, Calif.
KEY EXECUTIVES:
Fujio Mitarai, Chairman and CEO, Canon Global
Toshizo Tanaka, Exec. VP and CFO, Canon Global
Toshio Homma, Exec. VP and Chief Technology Officer, Canon Global
Yuji Hamada, President and CEO, Canon Medical Systems USA Inc.
John Patterson, Sr. VP, CFO and Treasurer, Canon Medical Systems USA Inc.
Satrajit Misra, Chief Sales and Marketing Officer, Canon Medical Systems USA Inc.
Canon Group’s medical division developed and offered a suite of total solutions for diagnosing COVID-19 infections last year, including CT equipment, diagnostic X-ray and ultrasound systems, rapid genetic testing, and rapid antigen testing.
The firm also partnered with Japan’s Nagasaki University to develop and launch reagents for clinical COVID-19 RNA testing for novel coronavirus genes, used to test crew members and passengers of a cruise ship stuck in Nagasaki. Developed through joint research with Yokohama City University, Canon Medical launched sales of a COVID-19 antigen test kit as well. In the U.K., the Bradford Royal Infirmary took delivery of a Relocatable CT scanner equipped with a complete X-ray diagnostic system, making diagnostic imaging possible wherever needed and reducing infection risk among healthcare professionals.
Canon’s Medical Systems business comprised 13.8 percent of the company’s sales last year. The franchise offers digital radiography systems, diagnostic X-ray and ultrasound systems, CT and MRI scanners, clinical chemistry analyzers, and ophthalmic equipment.
The business segment accrued $4.22 billion of revenue last year, almost a 5 percent drop from the year prior. COVID-19 caused the delay of large equipment installations and business negotiations, but CT system demand for pneumonia diagnosis helped prevent further revenue losses. Diagnostic X-ray demand was also strong due to support to emergency medical system maintenance.
Last February the firm achieved FDA clearance for its Aquilion ONE/PRISM Edition CT scanner that enabled deep learning spectral capabilities for more routine spectral imaging. The clearance helps make more confident diagnoses thanks to rapid kV switching with patient-specific mA modulation, full field of view acquisition, and 16 cm of coverage.
A month later, the company won 510(k) clearance for Advanced intelligent Clear-IQ Engine (AiCE) on its Vantage Galan 3T MR system. Trained using enormous amounts of high-quality image data, AiCE’s deep learning neural network reduces noise and boosts signal to acquire sharp, clear, and distinct images. Vantage Galan 3T was also FDA cleared for Compressed SPEEDER technology in March, which speeds MRI scan times by reconstructing full-resolution images from under-sampled data via iterative reconstruction. In June, the technology was cleared for the Vantage Orian 1.5T MR system. Vantage Orian 1.5T MR was FDA cleared for AiCE technology in July as well.
Last April saw the release of the Aquilion Prime SP CT system, a deployable CT with a rapid decontamination solution. It’s deployable in a modular or mobile configuration, and its automated UV-C technology significantly reduces bacteria, spores, and viruses. Multiple UV-C emitters collaborate to decontaminate the room in minutes.
Designed for structural and coronary imaging’s evolving needs, the Aquilion ONE/GENESIS SP cardiovascular CT was introduced last July. It touts one-beat, whole heart acquisition and AiCE Deep Learning Reconstruction (DLR), automated tools from acquisition through analysis, a lower total cost of ownership, a 78 cm bore, and a wide and low couch.
Canon Medical launched the SOLTUS 500 mobile digital X-ray in August. It has a compact design with features to promote efficiency and safety, including tubehead controls and touchscreen display, increased detector wireless range and productivity, anti-collision technologies, pressure-sensitive steering, and simplified detector charging and storage capacity.
Aquilion Exceed LB CT was introduced during last October’s American Society for Radiation Oncology (ASTRO) annual meeting. It features AiCE DLR technology, a 90 cm bore opening, edge-to-edge extended field-of-view reconstruction, and 4 cm of detector coverage. The system is still pending FDA 510(k) clearance.
In November, the firm expanded AiCE DLR to additional modalities, clinical indications, and systems. It showcased AiCE DLR for the Cartesion Prime Digital PET/CT system at last year’s Radiological Society of North America (RSNA) meeting. The indication is pending FDA clearance.
The OMNERA 500A digital radiography system rolled out in November. The system enhances productivity via quiet, smooth auto-positioning, tube and detector auto-tracking, titling wall stand synchronization, and table/wall stand detector charging. System controls are strategically placed on the overhead tube crane (OTC). A specifically designed glass overlay OTC display facilitates cleaning and disinfection.
Also in November, Canon introduced Deep Learning Spectral CT for cardiovascular imaging, which enabled one-beat spectral cardiac CT imaging on the Aquilion ONE/PRISM edition CT. Thanks to a 16 cm wide area detector, the whole heart can be imaged in as little as 0.275 seconds, according to the company.
November was a very busy month for Canon Medical: it also saw the release of Automation Platform AUTOStroke software for CT scanners. The clinical workflow automation solution for CT uses deep learning AI algorithms to automatically complete stroke triage and identify large vessel occlusions or intracranial hemorrhages. When it spots a critical case needing immediate attention, it sends an alert so clinicians can mobilize and respond as quickly as possible.
The Aplio i-series ultrasound platform was endowed with a new liver reporting tool in December. The program uses measurements gathered via Shear Wave Elastography, which provides quantitative measure and dynamic visual display of liver tissue stiffness. The system also provides standard deviation and interquartile range data, as well as a simple visual propagation map, to ensure an accurate and confident “Rule of Four” application to determine cACLD and for assessment of other liver pathologies.
The company unveiled three expanded digital service solutions in December:
- Gateway Platinum MVS: A cybersecurity solution with multi-vendor support
- Glassbeam Clinsights: valuable analytics for increased productivity
- PartsSource: An e-commerce distribution marketplace
A new size for the Hi-Def flat panel detector was introduced in December as well. According to Canon, the 12×16 Hi-Def detector provides over twice the spatial resolution of conventional flat panel detectors, helping see fine details in complex abdominal and peripheral procedures, including peripheral vessel stent placements, GI bleeding embolization, and endovascular leak repairs. The new size was made available for the Alphenix Sky + and Alphenix 4D CT with Sky + systems.
Compressed SPEEDER technology was FDA-cleared for 3D sequences on the Vantage Orian 1.5T in December. Compressed SPEEDER 3D boosts MRI scan times during 3D sequences for surgical planning and orthopedic applications by reconstructing full resolution images from under-sampled data through iterative reconstruction.